WFH ... WTF ... ????: Working-from-home, employer reaction and pandemic-inspired industrial changes
Brendan Shaw "If after 15 months, you have only a 'suspicion' about what your people are up to and find it 'hard to know' who are your...
top of page
Our Blog
See below for an opinion on current matters around the world.
Search
Brendan Shaw
Oct 21, 20231 min read
Time to Build More Windmills: Reflections from the ChinaBio Innovation & Investment Conference 2023
Brendan Shaw Article published in PharmaBoardroom 19 October 2023 that can be found here: https://pharmaboardroom.com/articles/time-to-bu...
8 views0 comments
Brendan Shaw
Aug 30, 20221 min read
Arm Doors and Cross-Check: What the Health Sector Can Learn from the Post-COVID Airline Industry
Brendan Shaw Article "Arm Doors and Cross-Check: What the Health Sector Can Learn from the Post-COVID Airline Industry Debacle",...
24 views0 comments
Brendan Shaw
Aug 19, 20218 min read
Workers of the world resign!: What if post-pandemic staff refuse to return to the office?
Brendan Shaw "Natural ragione è di ciascuno che ci nasce, la sua vita, quanto può, aiutare e conservare e difendere (Every person born...
163 views0 comments
Brendan Shaw
May 24, 20211 min read
Opportunities for the Life Science Industry in Australia post-COVID
Brendan Shaw Article published 24 May 2021 on opportunities for Australia's life science sector in a post-COVID world can be found here....
10 views0 comments
Brendan Shaw
Oct 1, 20208 min read
The new frontier: emerging regulatory issues in cell and gene therapies
Sunayana Shah and Brendan Shaw Cell and gene therapies promise great clinical value for patients, society, and healthcare systems. They...
279 views0 comments
Brendan Shaw
Jun 10, 20201 min read
Creeping Through the Backdoor: Disruption in Medicine and Health
Brendan Shaw and Orin Chisholm Article published in the journal Frontiers in Pharmacology on 10 June 2020 on whether health systems can...
18 views0 comments
Brendan Shaw
Jun 3, 20205 min read
When profit isn’t everything: 46,000 years of cultural history vs the iron ore spot price
Brendan Shaw “Our people are deeply troubled and saddened by the destruction of these rock shelters and are grieving the loss of...
212 views0 comments
Brendan Shaw
May 31, 20203 min read
Space X and NASA: lessons on public-private R&D for the health debate
Brendan Shaw On 30 May, the Space X Dragon rocket blasted off from the Kennedy Space Centre in Florida and delivered two NASA astronauts...
65 views0 comments
Brendan Shaw
Apr 16, 20201 min read
New industrial policy for biopharmaceutical and devices industry needs careful thought
Article published in BioPharmaDispatch on 17 April 2020 about the debate in Australia on expanding national manufacturing capacity in...
12 views0 comments
Brendan Shaw
Jun 20, 20195 min read
HTA 2.0: time for a reboot
A few days spent at the Health Technology Assessment International (HTAi) 2019 conference in Cologne this week gave a sense of how the...
202 views0 comments
Brendan Shaw
Apr 18, 20192 min read
Alzheimer's failure a lesson in why pharma companies are vital
News that a joint research project by pharmaceutical companies Biogen and Eisai to develop a new drug to treat Alzheimer's Disease has...
57 views0 comments
Brendan Shaw
Nov 16, 20185 min read
Crouching dragons and hidden tigers: the emergence of China’s life sciences sector
"Our greatest glory is not in never falling, but in rising every time we fall" - Confucius China’s life sciences industry is still...
111 views0 comments
Brendan Shaw
Oct 20, 20184 min read
My failure as a Rockstar: lessons from technological change in the music industry
In 2001, a little-known rock band started and ended its career in Melbourne, Australia. The band, Boxer, a folk-rock/pop band with a...
87 views0 comments
Brendan Shaw
Sep 24, 20184 min read
Doing it for Jane: eradicating tuberculosis
Sometimes in discussions of global health we get lost in the numbers. It's something I am often guilty of myself. Individual stories of...
40 views0 comments
Brendan Shaw
Jun 28, 20185 min read
To price or not to price, that is the question
What price to put on a medicine is one of the big issues in global health right now. While there are times when the debate around drug...
45 views0 comments
Brendan Shaw
May 31, 20185 min read
Don't forget the future: Alzheimer's disease and the economics of drug development
The story of the pharmaceutical industry’s efforts to find a treatment for Alzheimer’s disease is a classic example of why a commercially...
111 views0 comments
Brendan Shaw
Mar 22, 20186 min read
Disruptive innovation in the health sector – are we ready for it?
“Breaking an old business model is always going to require leaders to follow their instinct. There will always be persuasive reasons not...
219 views0 comments
Brendan Shaw
Mar 12, 20183 min read
Innovation policy is the new black
When I was a young economist starting my career in government many years ago I wasn't part of the 'in' crowd. I believed in a clever,...
44 views0 comments
Brendan Shaw
Jan 26, 20186 min read
Memo to life sciences executives: Happy New Year, take a deep breath and think big
As life sciences companies head into their annual strategic kick-off meetings for the year, spare a thought for their CEOs and senior...
63 views0 comments
bottom of page